Berenberg Says 'Time to Buy' BioNTech (BNTX) Following Management Meeting
Tweet Send to a Friend
Berenberg analyst Shanshan Xu reiterated a Buy rating and $312.00 price target on BioNTech (NASDAQ: BNTX)The analyst comments "We recently ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
